Opioid Prescribing Practices and Training Needs of Québec Family Physicians for Chronic Noncancer Pain

Table 3

Prescription opioid preferences.

	Always	Frequently	Occasionally	Never
	%	%	%	%
Short-acting drugs
Morphine	1.2	34.7	48.9	15.3
Hydromorphone	1.25	33.2	48.9	16.7
Tramadol/acetaminophen	1.02	23.7	51.0	24.3
Codeine/acetaminophen	1.1	18.1	44.9	36.0
Oxycodone	0.7	13.7	47.4	38.3
Tramadol	0.3	14.1	44.3	41.4
Codeine	0.5	7.3	35.4	56.9
Oxycodone/acetaminophen	0.2	3.7	23.4	72.8
Hydrocodone	0.4	1.7	11.0	87.0
Tapentadol	0.2	1.1	10.2	88.5
Meperidine	0.2	0.6	9.1	90.2
Nasal butorphanol	0	0.4	1.5	98.1
Long-acting drugs
Morphine	1.0	25.1	45.2	28.8
Hydromorphone	0.5	26.4	38.8	34.4
Transdermal fentanyl	0.3	15.5	42.1	42.0
Oxycodone	0.3	12.0	44.8	42.9
Tramadol	0.2	14.9	41.8	43.1
Codeine	0	5.1	27.6	67.3
Transdermal buprenorphine	0.2	3.0	21.8	75.1
Tapentadol	0.3	1.7	9.9	88.5
Methadone	0	2.0	5.6	92.5

Weighted proportions.